QDIS Blog

A blog about chemistry, drug development, science, and technology

July 9, 2007

Allos’ Brain Cancer Drug Fails Phase 3 Trials

by Ed Vawter @ 10:37 am.  Filed under Pharma News

Allos had a disappointing failure in phase III for efaproxyn for treatment of brain cancer that originated from breast cancer.

Allos’ Brain Cancer Drug Flops in Phase 3 - Health - RedOrbit:

In typical upbeat company fashion, they said they were disappointed but immediately started proclaiming their pipeline and how promising it is. This seems to be very common these days. I know there is the need to proclaim \the positive and negate the negatives but it seems to be out of balance in many of these sorts of press releases.

Technorati Tags:

Email Ed Vawter



Related Posts:
  • Telik Cancer Drug Failure
  • Neopharm Drug IL-13 Fails in Late Stage Clinical Trials
  • Are There Enough Volunteers to Run All the Cancer Clinical Trials?
  • Genentech Caps Cost of Cancer Drug for Some
  • Drug Safety Data from Clinical Trials

    • Bookmark it with: | del.icio.us del.icio.us | Digg It Digg it | Furl Furl | Simpy Simpy | Spurl Spurl | My! Yahoo My Yahoo! |

    Leave a Reply

    [powered by WordPress.]

    QDIS: blogging about chemistry, drug development, science and technology.

    Internal Links

    Categories

    Search This Blog

    Archives

    July 2007
    S M T W T F S
    « Jun   Aug »
    1234567
    891011121314
    15161718192021
    22232425262728
    293031  

    Search Entire Site

    Subscribe (It's Free!)

    Performancing

    Chemistry, science, and technology for the future.

    logo2

    General Links

    Blog Links

    Chemistry Journal Feeds

    Chemistry Feeds

    35 queries. 0.967 seconds